Health Care Adjustment Topic Analysis (I): Negative List of Drugs!

On April 29, the State Insurance Administration publicly solicited opinions on the Interim Measures for the Administration of Drug Use for Basic Medical Insurance (Draft for Comments), on April 29The main contents of the Opinion Draft are the formulation and adjustment rules of the Drug Catalog, and the management of the payment and use of medical insurance drugsThe former is the focus of high concern in the industrythe Draft opinion will be the transfer of the catalog into two levels of direct and can be adjusted outIn the catalogue of drugs directly transferred out, one of the six cases, after expert evaluation, the Drug Catalog is directly transferred:drugs that have been revoked, revoked or cancelledby the drug regulatory department;today, the author tried to analyze, in the end what kind of varieties are included in the negative listIf there is a leak, wanwang guidancenegative inventory system is a model for government market access management, the government through market access management to achieve market participants when the market entry regulation, the theory is to avoid or reduce the risk solely due to the existence of "market failure" intervention, and this kind of intervention also reduces the probability of "government failure"China has extended and expanded the concept, thought and scope of application of the negative list, and after the new Drug Administration Law came into effect on December 1, 2019, some provincial and municipal drug regulatory departments have applied the negative list to the field of quality and safety of drug production for the first time, so as to effectively safeguard the safety of public drug useOn July 1, 2019, the Medical and Health Administration of the National Health and Health Commission issued a "notice on the issuance of the first batch of national key monitoring and rational drug use catalogues (chemicals and biological products)." The use of 20 drugs, including neurocone sin, will be monitored and the Catalog will be dynamically adjustedin addition to the province and city, in recent years, has also published the relevant local version of the key monitoring directory, as followsThe State Health Insurance Administration solicited opinions on the Guidance on the Establishment of a Credit Evaluation System for Drug Prices and Recruitment (Draft for Comments) (hereinafter referred to as "Opinions")The Opinion calls for the establishment of a trustworthy commitment system for the price and marketing behavior of pharmaceutical enterprises, the voluntary declaration of price and marketing breach of trust in pharmaceutical enterprises, the verification of information on price and marketing breach of trust in pharmaceutical enterprises, credit evaluation of price and marketing breach of trust in pharmaceutical enterprises, grading punishment for price and marketing breach of trust in pharmaceutical enterprises, and credit repair of price and marketing breach of trust in pharmaceutical enterprisesAmong them, the situation of loss of trust in pharmaceutical enterprises is divided into four categoriescomprehensive information shows that pharmaceutical enterprises will be punished to varying degrees if they have bid for inflated prices, price monopoly, low prices to disrupt the market, commercial bribery and so onThe establishment of these standards, means that pharmaceutical companies in the recruitment and marketing process, need to more rigorous lycinated and regulate their own behavior, otherwise included in the breach of trust, will be possible to lose the qualificationsOn May 6,, the Anhui Provincial Drug Administration publicly solicited the opinions of the "Negative List of Quality and Safety of Drug Production of Drug Licensing Holders (Drug Production Enterprises) in Anhui Province", for a total of 30 articlesAnhui has always been a trend guide for medical reform, the introduction of relevant policies are often used by the industry, the relevant documents issued by Anhui, from the perspective of market access, particularly worthy of attention and attentionOn August 1, 2017, the Chongqing Food and Drug Administration issued the "Two-Vote System" Negative List of the Implementation of the "Two-Vote System" by the 8th Office of the Director General of Chongqing Municipality, which listed six kinds of behaviors in the production and circulation of drugs listed as the "two-vote system" negative listThese six behaviors include:to regulate medical behavior, improve the effectiveness of treatment, reduce adverse reactions, so that patients get more safe and effective treatment, since 2014, Anhui Province, in accordance with the "National Health and Family Planning Commission on the 2014 antimicrobial drug clinical application management notice" (National Health Administration Medical Letter (2014) No300) issued a relevant notice on strengthening the management of intravenous fluids in Anhui Province medical institutionsSince then, various places on the clinical application of antimicrobial drugs management issued a relevant notice